WithMe Health, Inc. announced the closing of a Series B financing round of $20 million led by OMERS Ventures and with participation from existing investor Oak HC/FT, along with new investors Section 32, Shulman Ventures and MTS Ventures. WithMe Health tailors medication recommendations and member support to an individual’s needs and context by assimilating multiple data sources (pharmacy, medical and lab) to develop an integrated clinical point-of-view.
In addition to providing a full-service replacement for traditional PBMs, WithMe Health is launching a medication guidance service that complements plan sponsors’ existing PBM infrastructure by personalizing medication selection and member guidance. The service helps employers and health plans curb their costs while optimizing member experience and outcomes.
Michael Yang, Managing Partner of OMERS Ventures, will join WithMe Health’s Board of Directors and Brian Marcotte, past CEO and President of the Business Group on Health, will join the Advisory Board. Coupled with recent partnerships with Centivo and Consociate Health, the new funding will support further growth of the client base as well as an extension of the core offering.
WithMe Health was founded on the belief that improved health outcomes and lower total cost of care can be achieved through better medication guidance. Their personalized medication guidance solution tailors medication selection to the individual and guides members through their medication journey. The company is headquartered in Silicon Valley, California, and has raised $40 million.
This was reported by WithMe Health, Inc. on November 24, 2020.
Contact information: WithMe Health, Inc., 400 South El Camino Real, Suite 1150, San Mateo, CA, 94402; https://www.withmehealth.com/